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Introduction
Positron emission tomography (PET) is a useful diagnostic 
procedure in cancer patients [1]. In particular, the combined 
use of  PET and Computed Tomography (CT) (PET/CT) led 
to a change in the clinical management of  36% of  patients with 
recurrent or metastatic colorectal cancer [2]. In oncological 
patients, serum tumor markers increasing, is highly suspected for 
presence of  disease and PET/CT with fluorodeoxyglucose ([18F]
FDG) can modify patient’s management revealing the precise site 
of  neoplastic foci.
Case Report
A 63-year-old female with clinical history of  colon cancer was 
referred to our Institute for a mild increase of  carcino-embryonic 
antigen (CEA) serum level. In 1997 the patient was submitted 
to left colectomy for adenocarcinoma (pT3; pN0). Adjuvant 
chemotherapy was carried out without significant effects. In 
the follow-up the patient performed abdomen ultrasound every 
two years and laboratory tests every year. In the last six months 
a slow and persistent CEA serum level increasing was evident. 
On physical examination, she was asymptomatic. Abdominal 
ultrasound showed a single liver lesion in the segment II, and 
portal thrombosis (Figure 1). Multi-detector CT (MDCT) 
revealed a liver nodule suggestive for metastatic lesion and portal 
thrombosis with no enhancement (Figure 2). The undetermined 
nature of  the portal thrombosis pointed out the indication of  
completing the patient’s staging with [18F] FDG PET/CT. In 
fasting conditions and euglicemic state, 370 MBq of  [18F] FDG 
were intravenously injected and after 50 minutes a PET/CT scan 
was carried out. Total body scan revealed two areas of  intense 
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[18F] FDG uptake in liver parenchyma (Figure 3). 
The first area corresponded to the liver nodule revealed 
by abdomen ultrasound and MDCT. This lesion was later 
histologically confirmed to be neoplastic through an US-guided 
liver biopsy. The second report, analyzing MDCT and PET/CT 
imaging, corresponded to the portal thrombosis (Figure 4). No 
other abnormal areas of  [18F] FDG uptake were revealed in the 
scan. 
Because of  intense [18F] FDG uptake, no signs and/or symptoms 
of  acute thrombosis, its upstream location, no enhancement on 
MDCT and no vascolarization on color-Doppler ultrasound we 
interpreted the thrombosis as neoplastic. 
Based on this consideration, no anti-thrombotic drugs were 
administered. Patient underwent four courses of  chemotherapy 
(eloxatin combined with 5-Fluorouracil and leucovorin) without 
significant collateral effects. 
At the end of  chemotherapy an evaluation through abdomen 
ultrasound and CT documented significant reduction of  
dimension of  liver lesion and disappearance of  portal thrombosis. 
Two weeks following chemotherapy patient underwent surgery 
for liver metastasectomy. The intraoperative ultrasound of  portal 
thrombosis resulted completely normal in the remnant liver.
Discussion
In this case conventional imaging findings were not pathognomic 
for the neoplastic nature of  thrombosis but the characteristics 
of  each diagnostic procedures and the disappearance after 
chemotherapy without administration of  anti-thrombotic drugs 
resulted harmonious.
[18F] FDG PET/CT and CT, sometimes, are complementary 
techniques in staging and restaging patients with colorectal cancer. 
The combination of  these two modalities may significantly 
impacts upon patient management.
Some 50% of  patients with colorectal cancer develop liver 
metastases and die of  their disease (3). Surgical resection of  
colorectal metastases improves 5-year survival between 25 
and 40%. Surgical failure and recurrent disease may be due to 
inadequate initial evaluation of  metastatic disease [4-6].
Likely, [18F]FDG PET/CT can detect neoplastic foci in the 
vascular district, helping morphological imaging in a more specific 
diagnosis.
This finding support the use of  [18F] FDG PET in the follow-
up of  patients with suspected colorectal liver metastases and 
equivocal findings on conventional diagnostic investigation.
Figure 1. Abdominal ultrasound shows a single liver lesion in the segment II (white arrow), and portal thrombosis (black 
arrow). 
Figure 2. Multi-detector abdominal CT scan with contrast enema reveales a liver nodule suggestive for metastatic lesion and 
portal thrombosis with no enhancement (black arrow).
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Figure 3. Total body CT scan with contrast enemareveales two areas of  intense [18F]FDG uptake in liver parenchyma 
(black arrows). The first area corresponds to the liver nodule revealed by abdomen ultrasound and CT.
Figure 4. Analyzing CT scan and PET/CT imaging, the image corresponds to the portal thrombosis only (black arrows).
